Bio-Rad Laboratories, Inc.
BIO
$245.01
-$6.14-2.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -304.67% | 514.71% | -86.32% | 456.71% | -57.75% |
| Total Depreciation and Amortization | 5.38% | 4.29% | 1.68% | 4.21% | 4.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 441.52% | -1,628.60% | 80.93% | -1,296.87% | 68.01% |
| Change in Net Operating Assets | -2,534.15% | 8,928.00% | -77.97% | 234.00% | -105.58% |
| Cash from Operations | 53.33% | 67.39% | -0.43% | -28.87% | 1.75% |
| Capital Expenditure | -1.54% | 8.72% | -22.06% | -12.46% | -21.47% |
| Sale of Property, Plant, and Equipment | -151.04% | -12.31% | 69.23% | -- | 104.26% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.90% | -144.82% | -81.96% | 91.53% | 569.91% |
| Cash from Investing | -142.31% | -485.64% | -210.52% | 38.85% | 223.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 72.85% | -4.24% | -1.72% | -2.61% | -5.59% |
| Issuance of Common Stock | -9.74% | 9.79% | -8.12% | 24.43% | -0.23% |
| Repurchase of Common Stock | 99.93% | -224.36% | 51.30% | -- | -125.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.91% | -260.88% | 52.36% | -99.51% | -131.56% |
| Foreign Exchange rate Adjustments | 257.46% | -220.80% | 43.70% | 233.42% | 64.31% |
| Miscellaneous Cash Flow Adjustments | -1,300.00% | 1,300.00% | -- | -- | -91.49% |
| Net Change in Cash | 244.01% | -93.41% | 64.83% | -1.92% | 35.64% |
